
Overview
John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors.
Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Severe Congenital Neutropenia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Gastrostomy.
His clinical research consists of co-authoring 17 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center At John P. Murtha Pavilion
Ibrahim Sbeitan, MD, specializes in hematology oncology and is board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. He practices at UPMC Hillman Cancer Center. Dr. Sbeitan received his medical degree from the University of Jordan School of Medicine and completed his residency at Gundersen Medical Foundation in La Crosse, Wisconsin, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Sbeitan is rated as a Distinguished provider by MediFind in the treatment of Severe Congenital Neutropenia. His top areas of expertise are Chronic Familial Neutropenia, Lynch Syndrome, Paget Disease of the Breast, and Urothelial Cancer.
UPMC Hillman Cancer Center
Grace R. Tarabay-Caridad, MD, is a medical oncologist at UPMC Hillman Cancer Center, Beaver. Board-certified in internal medicine, oncology, and hematology, Dr. Tarabay-Caridad received her medical degree from American University of Beirut Medical Center in Beiruit, Lebanon. She completed her fellowship at St. Vincent;s Comprehensive Cancer Center in New York and her residency at Staten Island University Hospital in New York. Dr. Tarabay-Caridad is rated as a Distinguished provider by MediFind in the treatment of Severe Congenital Neutropenia. Her top areas of expertise are Budd-Chiari Syndrome, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Bone Marrow Aspiration.
UPMC Hillman Cancer Center
Yehuda Lebowicz, MD, is a medical oncologist and hematologist and specializes in the treatment of all leukemia, lymphoma, and lung cancer cases. Dr. Lebowicz is rated as a Distinguished provider by MediFind in the treatment of Severe Congenital Neutropenia. His top areas of expertise are Pleuropulmonary Blastoma, Inflammatory Breast Cancer, Angiosarcoma, Breast Cancer, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Rhee isDistinguished. Learn about Lung Cancer.
- MesenchymomaDr. Rhee isDistinguished. Learn about Mesenchymoma.
- Pleuropulmonary BlastomaDr. Rhee isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Rhee isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Undifferentiated Pleomorphic SarcomaDr. Rhee isDistinguished. Learn about Undifferentiated Pleomorphic Sarcoma.
- Advanced
- Adult Soft Tissue SarcomaDr. Rhee isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Bone TumorDr. Rhee isAdvanced. Learn about Bone Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)
- EGFR Positive Lung CancerDr. Rhee isAdvanced. Learn about EGFR Positive Lung Cancer.
- Epithelioid SarcomaDr. Rhee isAdvanced. Learn about Epithelioid Sarcoma.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Rhee isExperienced. Learn about Adenoid Cystic Carcinoma.
- AgranulocytosisDr. Rhee isExperienced. Learn about Agranulocytosis.
- Alveolar Soft Part SarcomaDr. Rhee isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Ampullary CancerDr. Rhee isExperienced. Learn about Ampullary Cancer.
- Anal CancerDr. Rhee isExperienced. Learn about Anal Cancer.



